4//SEC Filing
Clark Kenneth A 4
Accession 0001599298-24-000150
CIK 0001599298other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 5:08 PM ET
Size
5.7 KB
Accession
0001599298-24-000150
Insider Transaction Report
Form 4
Clark Kenneth A
Director
Transactions
- Award
Stock Option (right to buy)
2024-10-11+200,000→ 200,000 totalExercise: $19.95Exp: 2034-10-11→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]The option was granted on October 11, 2024. The shares underlying the option shall vest in four equal annual installments, subject to the reporting person continuing to serve as a member of the Strategic Advisory Committee of the Board, with the first installment occurring on October 11, 2025.
- [F2]Not applicable.
Documents
Issuer
Summit Therapeutics Inc.
CIK 0001599298
Entity typeother
Related Parties
1- filerCIK 0001561736
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 5:08 PM ET
- Size
- 5.7 KB